Increasing influenza and pneumococcal vaccine uptake in the elderly - The Vaccination60+ study
Not Applicable
Recruiting
- Conditions
- J10J18R65.1R65.0R57.2Influenza due to identified seasonal influenza virusPneumonia, organism unspecifiedSystemic Inflammatory Response Syndrome of infectious origin with organ failureSystemic Inflammatory Response Syndrome of infectious origin without organ failureSeptic shock
- Registration Number
- DRKS00012653
- Lead Sponsor
- niversität Erfurt
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 2182000
Inclusion Criteria
State of residence: Germany
Exclusion Criteria
age <60 years
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcomes are reasons for non-vaccination and determinants of vaccination behavior as well as uptake rates of influenza and pneumococcal vaccination. These outcomes are measured by a representative telephone survey in Thuringia and other federal countries, as well as the assessment of vaccination rates using routine data by the Kassenärztliche Vereinigung Thüringen during and after the first and second wave of the intervention (autumn and winter 2017/2018 and 2018/2019).
- Secondary Outcome Measures
Name Time Method Secondary outcomes are the reduction of influenza, pneumonia, pneumococcal bacteremia and sepsis incidence in the target group. As a tertiary outcome the reduction of the economic burden of influenza, pneumonia and sepsis for the healthcare system will be assessed. Secondary and tertiary outcomes are assessed after the intervention using different data sources such as the nationwide DRG statistics by the Federal Statistics Office, the Alertsnet Registry for bloodstream infection in Thuringia, claims data of a major social health insurance (AOK PLUS) and data of the Multidisciplinary Quality Assurance in the Health Care System (SQG data).